Navigation Links
More Support for Zinc-antiatherogenic Link

Researchers investigating the link between zinc supplementation and reduced atherosclerosis in rabbit models have used a different method// to lend support to their hypothesis that the effect may be due to a reduction in iron-catalyzed free radical reactions.

Researchers from the National University of Singapore reported in the journal Free Radical Biology and Medicine last year that supplementation of a high cholesterol diet with zinc reduced the formation of lesions in the arteries of rabbits, but said that the effects were not linked to changes in levels.

Rather, the decrease in atherosclerotic lesions was linked to a decrease in iron concentrations in the tissue, which has previously been reported to catalytically promote damaging free-radical reactions and the development of atherosclerosis.

The findings of their latest research in this area are reported in the same journal this month. Atherosclerosis, whereby fatty substances such as cholesterol and calcium form plaque on the inner lining of an artery, is a risk factor for cardiovascular disease. If they can be translated to humans they could contribute to understanding of nutritional measures to preserve heart health.

The new study involved two groups of New Zealand white rabbits that were both fed a high cholesterol diet over an eight-week period. One of the groups also received zinc supplements at levels of 1g per kg of body weight. A control group was fed a normal diet.

The aim of the researchers, led by Barry Halliwell from the National University of Singapore, was to examine the role of zinc on lipid peroxidation in relation to atherosclerosis. They used isotope dilution gas chromatography-mass spectrometry techniques to measure biomarkers of oxidative lipid damage in atherosclerotic rabbit aorta.

In the past the research team used F(2)-isoprostane measurement. But since analysis of different biomarkers often requires different protocols, it adapted this technique to include the quantitation of cholesterol oxidation products in the same sample.

Halliwell's team found that zinc supplementation did not have a significant impact on the increase in total blood cholesterol levels in animals fed high cholesterol, but it did seem to significantly reduce the accumulation of total cholesterol levels on arterial walls.

In the cholesterol diet group cholesterol concentration levels were seen to be around 11.5 mg/g tissue, compared to around 4.5 mg/g tissue in the cholesterol diet plus zinc group.

Average aortic lesion cross-sectional areas were around 3mm2 in the cholesterol diet group, but only around 1.5mm2 in the cholesterol diet plus zinc group.

They also observed that elevated levels of cholesterol oxidation products (5,6-alpha and beta cholesterol epoxides, 7beta-hydroxycholesterol, 7-ketocholesterol) in aorta.

Total F(2)-isoprostanes in plasma of the rabbits that were fed a cholesterol diet were around 1.7 mg/ml in the cholesterol plus zinc group – on a par with the control group – compared to around 5.3 ng/ml in the cholesterol diet only group.

Likewise with total F(2)-isoprostane content in tissue, the cholesterol plus zinc group and control group had around 3.3ng/ml, compared to around 5ng/ml in the control group.

“Our data indicate that zinc has an anti-atherogenic effect, possibly due to a reduction in iron-catalyzed free radical reactions,” wrote the researchers.

“Since some groups of the population have deficient dietary intake or lower tissue levels of zinc reasonable supplementation of zinc in the diet of humans at risk of atherosclerosis should be considered as a strong candidate for further clinical investigation.”

However they said that the mechanism of action is still unclear, despite several studies demonstrating that zinc supplementation can reduce oxidative damag e. Since zinc is not redox active, it probably does not act directly as an antioxidant.

Atherosclerosis occurs naturally in humans as part of the aging process, but certain factors including high blood cholesterol, smoking, high blood pressure, obesity and diabetes increase the risk.

Zinc deficiency is known to lead to growth impairment, neuropathy, diarrhea, dermatitis, hypotension and hyperthermia.

Source-Bio-Bio TechnologySRM

Related medicine news :

1. Support therapy helps breast cancer patients
2. Support for patients with Leg Pain
3. WHO To Support Public Health Threats
4. Support Services found to Dramatically Impact Pediatric Health Care
5. Britney Spears Donates $50 000 To Support Cancer Patients
6. Supportive spouse help ease job strain on blood pressure
7. Biopsies Of Human Skin And Bone Marrow Support T Cell Development
8. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
9. Blair Offers James Support To Fight AIDS
10. Cancer Cells Trigger Supporting Cells to Turn Cancerous
11. Guru’s Supporters Clash With CPI-M Me
Post Your Comments:

(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new ... systems. The new app features a more intuitive SleepScore™ that rates sleep quality on ... slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to ...
(Date:11/25/2015)... ... ... In an ongoing Clinical Study conducted by an independent physician, Andrew Gostine, ... evaluating the efficacy of its product and its disinfection protocol. This study is taking ... 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in Chicago, ...
(Date:11/25/2015)... D.C. (PRWEB) , ... November 25, 2015 , ... Today, ... fatalities on our nation’s roadways has dropped below 10,000 for the first time since ... 10,076 in 2013. , According to data released by the National Highway Traffic Safety ...
(Date:11/25/2015)... Md (PRWEB) , ... November 25, 2015 , ... ... Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for ... of this disease. The Periwinkle Pioneers, nominated by the public, will receive special ...
(Date:11/25/2015)... Florida (PRWEB) , ... November 25, 2015 , ... ... LLC has announced that it has undertaken significant expansion of its current state ... The investment is part of PharmaTech’s strategy to increase its manufacturing capacity as ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Calif. , Nov. 24, 2015 /PRNewswire/ ... leader in non-invasive genetic testing and the ... that it will present at the 27 ... York on Wednesday, December 2, 2015 at 1:00 p.m. ET.  Matthew Rabinowitz, ... Company,s financial results, business activities and financial ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
(Date:11/24/2015)... Nov. 24, 2015  DILON Diagnostics and GE Healthcare ... agreement for DILON to distribute GE,s Discovery NM750b Molecular ... signing of this distribution agreement will provide Dilon,s experienced ... Imaging system and is considered an initial step in ... solutions for clinicians and their patients. ...
Breaking Medicine Technology: